Sanofi seeks FDA approval of flu vaccine with smaller needle

09/13/2010 | Reuters

The FDA has accepted Sanofi-Aventis' application for flu vaccine Fluzone, which is administered with a short and thin needle. The vaccine, which is approved in Europe, requires less of the active ingredient, antigen.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ